Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Vitamin B12 Supplementation: Is More Always Better?

  • 2026-05-18
  • Nutrients 18(10)
    • Manuela Yepes-Calderón
    • Caecilia S E Doorenbos
    • Mariken E Stegmann
    • Daan J Touw
    • Hermie J M Harmsen
    • M Rebecca Heiner-Fokkema
    • Francjan J van Spronsen
    • Eva Corpeleijn
    • Stephan J L Bakker

Study Design

Type
Review
Population
general populations of high-income countries (~2%), settings with limited access to animal-source foods or B12-fortified products (up to 69%)
Methods
We present guidance from major health authorities, advises against routine testing in asymptomatic individuals without risk factors. Studying the effects of supplementation challenged by variation in regimens, range from 0.02 to 1 mg/day orally and from 1 to 5 mg/week intramuscularly, durations spanning ~4 weeks to ~7 years
Duration
~4 weeks to ~7 years
  • Rigorous Journal
Vitamin B12 supplementation among people without proven deficiency has become popularized, driven by perceptions of (i) frequent underdiagnosis of deficiency, (ii) promotion as a natural enhancer of well-being, and (iii) a favourable safety profile. Here, we examine whether these claims align with current evidence. We present guidance from major health authorities, which advises against routine testing in asymptomatic individuals without risk factors. The prevalence of B12 deficiency varies greatly, mainly because definitions of B12 deficiency are not standardized and may include clinical, biochemical, or functional criteria. Biochemical deficiency (typically serum B12 < 148 pmol/L) is the predominant definition in epidemiological and clinical research studies. Using this criterion, deficiency appears uncommon in general populations of high-income countries (~2%), but substantially more frequent in settings with limited access to animal-source foods or B12-fortified products (up to 69%). Studying the effects of supplementation is also challenged by variation in the regimens used, which range from 0.02 to 1 mg/day orally and from 1 to 5 mg/week intramuscularly, with durations spanning ~4 weeks to ~7 years. This limits cross-study comparability. Overall, supplementation has not shown consistent benefits in populations without overt clinical or biochemical B12 deficiency, with no clear improvements in fatigue, mood, cognition, or cardiovascular outcomes. Benefits, when reported, appear confined to selected subgroups (e.g., hyperhomocysteinemia or low-normal B12 status). B12 supplementation is generally well tolerated. There are rare reports of acneiform and hypersensitivity responses, although these cannot be completely distinguished from reactions to, e.g., excipients. Observational studies associate B12 supplementation and higher circulating B12 levels with increased risks of malignancy. However, these findings are inconsistent, and current evidence is insufficient to establish causality, as potential reverse causation remains a major concern.

Research Insights

  • Overall, supplementation has not shown consistent benefits in populations without overt clinical or biochemical B12 deficiency, with no clear improvements in fatigue, mood, cognition, or cardiovascular outcomes.

    Effect
    Neutral
    Effect size
    Small
    Dose
    0.02 to 1 mg/day orally and 1 to 5 mg/week intramuscularly, durations ~4 weeks to ~7 years
  • Overall, supplementation has not shown consistent benefits in populations without overt clinical or biochemical B12 deficiency, with no clear improvements in fatigue, mood, cognition, or cardiovascular outcomes.

    Effect
    Neutral
    Effect size
    Small
    Dose
    0.02 to 1 mg/day orally and 1 to 5 mg/week intramuscularly, durations ~4 weeks to ~7 years
  • Overall, supplementation has not shown consistent benefits in populations without overt clinical or biochemical B12 deficiency, with no clear improvements in fatigue, mood, cognition, or cardiovascular outcomes.

    Effect
    Neutral
    Effect size
    Small
    Dose
    0.02 to 1 mg/day orally and 1 to 5 mg/week intramuscularly, durations ~4 weeks to ~7 years
  • Overall, supplementation has not shown consistent benefits in populations without overt clinical or biochemical B12 deficiency, with no clear improvements in fatigue, mood, cognition, or cardiovascular outcomes.

    Effect
    Neutral
    Effect size
    Small
    Dose
    0.02 to 1 mg/day orally and 1 to 5 mg/week intramuscularly, durations ~4 weeks to ~7 years

Adverse Events Reported

  • Vitamin B12Overall tolerability

    B12 supplementation is generally well tolerated.

    Finding
    Reported
  • Vitamin B12acneiform

    There are rare reports of acneiform and hypersensitivity responses, although these cannot be completely distinguished from reactions to, e.g., excipients.

    Finding
    Reported
  • Vitamin B12hypersensitivity

    There are rare reports of acneiform and hypersensitivity responses, although these cannot be completely distinguished from reactions to, e.g., excipients.

    Finding
    Reported
  • Vitamin B12malignancy

    Observational studies associate B12 supplementation and higher circulating B12 levels with increased risks of malignancy. However, these findings are inconsistent, and current evidence is insufficient to establish causality, as potential reverse causation remains a major concern.

    Finding
    Reported
Back to top